Luther King Capital Management (LKCM)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $176M | Sell |
808,779
-32,920
| -4% | -$7.3M | 0.76% | 38 |
|
|
2025
Q4 | $192M | Buy |
841,699
+6,916
| +0.8% | +$1.58M | 0.78% | 32 |
|
|
2025
Q3 | $193M | Buy |
834,783
+989
| +0.1% | +$201K | 0.8% | 30 |
|
|
2025
Q2 | $155M | Sell |
833,794
-4,303
| -0.5% | -$800K | 0.67% | 43 |
|
|
2025
Q1 | $176M | Sell |
838,097
-5,175
| -0.6% | -$1.01M | 0.81% | 38 |
|
|
2024
Q4 | $150M | Sell |
843,272
-14,083
| -2% | -$2.59M | 0.65% | 45 |
|
|
2024
Q3 | $169M | Sell |
857,355
-9,151
| -1% | -$1.71M | 0.73% | 40 |
|
|
2024
Q2 | $149M | Sell |
866,506
-53,628
| -6% | -$8.88M | 0.67% | 44 |
|
|
2024
Q1 | $168M | Sell |
920,134
-5,121
| -0.6% | -$883K | 0.76% | 40 |
|
|
2023
Q4 | $143M | Sell |
925,255
-12,111
| -1% | -$1.77M | 0.69% | 43 |
|
|
2023
Q3 | $140M | Sell |
937,366
-6,570
| -0.7% | -$964K | 0.73% | 43 |
|
|
2023
Q2 | $127M | Sell |
943,936
-26,898
| -3% | -$3.94M | 0.63% | 45 |
|
|
2023
Q1 | $155M | Buy |
970,834
+1,004
| +0.1% | +$153K | 0.82% | 38 |
|
|
2022
Q4 | $157M | Sell |
969,830
-284
| -0% | -$43.5K | 0.86% | 37 |
|
|
2022
Q3 | $130M | Buy |
970,114
+7,013
| +0.7% | +$1.01M | 0.78% | 39 |
|
|
2022
Q2 | $148M | Sell |
963,101
-6,619
| -0.7% | -$1.01M | 0.83% | 38 |
|
|
2022
Q1 | $157M | Sell |
969,720
-51,406
| -5% | -$7.47M | 0.77% | 42 |
|
|
2021
Q4 | $138M | Buy |
1,021,126
+5,001
| +0.5% | +$591K | 0.63% | 47 |
|
|
2021
Q3 | $110M | Buy |
1,016,125
+9,217
| +0.9% | +$1.05M | 0.54% | 61 |
|
|
2021
Q2 | $113M | Buy |
1,006,908
+44,614
| +5% | +$5.02M | 0.55% | 59 |
|
|
2021
Q1 | $104M | Buy |
962,294
+23,335
| +2% | +$2.5M | 0.56% | 58 |
|
|
2020
Q4 | $101M | Buy |
938,959
+252
| +0% | +$24.2K | 0.57% | 52 |
|
|
2020
Q3 | $82.2M | Sell |
938,707
-5,513
| -0.6% | -$519K | 0.52% | 58 |
|
|
2020
Q2 | $92.7M | Sell |
944,220
-9,613
| -1% | -$846K | 0.64% | 46 |
|
|
2020
Q1 | $72.7M | Sell |
953,833
-76,248
| -7% | -$6.49M | 0.63% | 51 |
|
|
2019
Q4 | $91.2M | Sell |
1,030,081
-45,110
| -4% | -$3.74M | 0.61% | 53 |
|
|
2019
Q3 | $81.4M | Sell |
1,075,191
-134,819
| -11% | -$9.24M | 0.59% | 55 |
|
|
2019
Q2 | $88M | Sell |
1,210,010
-496,113
| -29% | -$39M | 0.64% | 54 |
|
|
2019
Q1 | $137M | Sell |
1,706,123
-179,646
| -10% | -$14.7M | 1.05% | 34 |
|
|
2018
Q4 | $174M | Sell |
1,885,769
-335,170
| -15% | -$29.5M | 1.55% | 15 |
|
|
2018
Q3 | $210M | Sell |
2,220,939
-368,979
| -14% | -$35M | 1.59% | 16 |
|
|
2018
Q2 | $240M | Buy |
2,589,918
+5,148
| +0.2% | +$503K | 1.96% | 8 |
|
|
2018
Q1 | $245M | Sell |
2,584,770
-8,906
| -0.3% | -$978K | 2.05% | 7 |
|
|
2017
Q4 | $251M | Buy |
2,593,676
+121,792
| +5% | +$11.5M | 2.05% | 5 |
|
|
2017
Q3 | $220M | Buy |
2,471,884
+22,506
| +0.9% | +$1.71M | 1.92% | 8 |
|
|
2017
Q2 | $178M | Buy |
2,449,378
+16,397
| +0.7% | +$1.1M | 1.61% | 11 |
|
|
2017
Q1 | $159M | Buy |
2,432,981
+32,920
| +1% | +$2.07M | 1.46% | 17 |
|
|
2016
Q4 | $150M | Buy |
2,400,061
+52,987
| +2% | +$3.23M | 1.43% | 18 |
|
|
2016
Q3 | $148M | Sell |
2,347,074
-25,597
| -1% | -$1.66M | 1.45% | 15 |
|
|
2016
Q2 | $147M | Sell |
2,372,671
-20,790
| -0.9% | -$1.27M | 1.44% | 12 |
|
|
2016
Q1 | $137M | Buy |
2,393,461
+38,722
| +2% | +$2.16M | 1.36% | 14 |
|
|
2015
Q4 | $139M | Sell |
2,354,739
-48,642
| -2% | -$2.8M | 1.31% | 15 |
|
|
2015
Q3 | $131M | Sell |
2,403,381
-211,717
| -8% | -$13.8M | 1.27% | 15 |
|
|
2015
Q2 | $176M | Sell |
2,615,098
-53,330
| -2% | -$3.48M | 1.52% | 7 |
|
|
2015
Q1 | $156M | Buy |
2,668,428
+5,186
| +0.2% | +$313K | 1.31% | 10 |
|
|
2014
Q4 | $174M | Buy |
2,663,242
+73,401
| +3% | +$4.63M | 1.41% | 8 |
|
|
2014
Q3 | $150M | Buy |
2,589,841
+257,830
| +11% | +$14.3M | 1.23% | 11 |
|
|
2014
Q2 | $132M | Buy |
2,332,011
+62,815
| +3% | +$3.3M | 1.04% | 18 |
|
|
2014
Q1 | $117M | Buy |
2,269,196
+7,251
| +0.3% | +$366K | 0.95% | 24 |
|
|
2013
Q4 | $119M | Buy |
2,261,945
+68,027
| +3% | +$3.34M | 0.96% | 20 |
|
|
2013
Q3 | $98.1M | Buy |
2,193,918
+18,604
| +0.9% | +$825K | 0.84% | 29 |
|
|
2013
Q2 | $89.9M | Buy |
+2,175,314
| New | +$95.1M | 0.84% | 28 |
|
Other funds holding ABBV
VCM
VPM
Luther King Capital Management (LKCM)'s ABBV Position: Q1 2026 in Review
Luther King Capital Management (LKCM) reduced its AbbVie (ABBV) stake by 3.9% in Q1 2026, selling an estimated $7.3M and leaving 808,779 shares worth $176M. The position accounts for 0.76% of the portfolio, ranked #38.
Luther King Capital Management (LKCM) first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $251M in Q4 2017. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Luther King Capital Management (LKCM) held 808,779 shares of AbbVie worth $176M as of Q1 2026.
- Luther King Capital Management (LKCM) sold 32,920 AbbVie shares in Q1 2026, an estimated $7.3M.
- AbbVie made up 0.76% of Luther King Capital Management (LKCM)'s portfolio in Q1 2026, its #38 holding.
- Luther King Capital Management (LKCM) first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Luther King Capital Management (LKCM)'s AbbVie position peaked at $251M in Q4 2017.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q1 2026, filed 11 May 2026.